Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecelatorpharma.com
CategoryBioTech
Phone(609) 243-0123
Emailinfo@celatorpharm...
Employees
Founded1999

Offices

Princeton, USA
303B College Road East
Princeton, NJ, 08540
USA

People

CEO
Board of Directors
Board of Directors

Funding

TOTAL $64.4M
FUNDING TOTAL $64.4M
Venture Round, 5/2010
$2.5M
Series D, 9/2010
Thomas, McNerney & Partners
Domain Associates
Ventures West
Quaker BioVentures
TL Ventures
GrowthWorks Capital
BDC Venture Capital
$20M
Partial Close, 12/2011
$2.58M
Private Equity, 4/2013
ROTH Capital Partners
Valence Life Sciences
$39.3M

Tags

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING (celatorpharma.com) [edit]
  3. SEC (sec.gov) [edit]
  4. CELATOR® PHARMACEUTICALS RAISES $32.5 MILLION COMPLETING A $39.3 MILLION PRIVATE PLACEMENT FINANCING (celatorpharma.com) [edit]
Edit This Page
Last Edited 12/9/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy